Design and delivery of camplatin to overcome cisplatin drug resistance

被引:32
|
作者
Qi, Ruogu [1 ,2 ]
Xiao, Haihua [1 ,2 ]
Wu, Suhong [1 ,2 ]
Li, Yuxin [3 ]
Zhang, Yu [3 ]
Jing, Xiabin [1 ]
机构
[1] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun 130024, Peoples R China
基金
中国国家自然科学基金;
关键词
OVARIAN-CANCER; CELLS; CARBOPLATIN; EFFICACY; PRODRUGS; BCL-2;
D O I
10.1039/c4tb01146e
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Camplatin, a prodrug formed via coining camphoric anhydride and cisplatin, was delivered in biodegradable nanoparticles. This camphoric acid and cisplatin co-delivery system exhibited enhanced anticancer activity compared to cisplatin and has successfully overcome cisplatin drug resistance.
引用
收藏
页码:176 / 179
页数:4
相关论文
共 50 条
  • [41] A tetranuclear platinum compound designed to overcome cisplatin resistance
    Jansen, BAJ
    van der Zwan, J
    Reedijk, J
    den Dulk, H
    Brouwer, J
    EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 1999, (09) : 1429 - 1433
  • [42] Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
    Zhen-duo Shi
    Lin Hao
    Xiao-xiao Han
    Zhuo-Xun Wu
    Kun Pang
    Yang Dong
    Jia-xin Qin
    Guang-yue Wang
    Xuan-ming Zhang
    Tian Xia
    Qing Liang
    Yan Zhao
    Rui Li
    Shao-qi Zhang
    Jun-hao Zhang
    Jian-gang Chen
    Gong-cheng Wang
    Zhe-Sheng Chen
    Cong-hui Han
    Molecular Cancer, 21
  • [43] Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
    Min, Yuanzeng
    Mao, Cheng-Qiong
    Chen, Siming
    Ma, Guolin
    Wang, Jun
    Liu, Yangzhong
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (27) : 6742 - 6747
  • [44] Iron chelators that overcome drug resistance
    Yamagishi, T.
    Jansson, P. J.
    Richardson, D. R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 103 - 103
  • [45] Drug repurposing to overcome microbial resistance
    Jampilek, Josef
    DRUG DISCOVERY TODAY, 2022, 27 (07) : 2028 - 2041
  • [46] Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance
    Szulc, Aleksandra
    Pulaski, Lukasz
    Appelhans, Dietmar
    Voit, Brigitte
    Klajnert-Maculewicz, Barbara
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 513 (1-2) : 572 - 583
  • [47] Nanoparticle delivery of a triple-action Pt(iv) prodrug to overcome cisplatin resistance via synergistic effect
    Xie, Peng
    Jin, Qiao
    Li, Yifan
    Zhang, Jinbo
    Kang, Xiang
    Zhu, Jialin
    Mao, Xinzhan
    Cao, Peiguo
    Liu, Chaoyong
    BIOMATERIALS SCIENCE, 2021, 10 (01) : 153 - 157
  • [48] Strategies to overcome the polycation dilemma in drug delivery
    Bernkop-Schnuerch, Andreas
    ADVANCED DRUG DELIVERY REVIEWS, 2018, 136 : 62 - 72
  • [49] Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer
    Senlin Li
    Siyu Chen
    Zhihui Dong
    Xingdong Song
    Xiuling Li
    Ziqi Huang
    Huiru Li
    Linzhuo Huang
    Ganyuan Zhuang
    Ran Lan
    Mingyan Guo
    Wende Li
    Phei Er Saw
    Lei Zhang
    Acta Pharmaceutica Sinica B, 2023, (03) : 967 - 981
  • [50] A self-assembled albumin based multiple drug delivery nanosystem to overcome multidrug resistance
    Chen, Bin
    Wu, Cong
    Zhuo, Ren-Xi
    Cheng, Si-Xue
    RSC ADVANCES, 2015, 5 (09): : 6807 - 6814